201 related articles for article (PubMed ID: 24315301)
1. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy.
Abelson B; Reddy CA; Ciezki JP; Angermeier K; Ulchaker J; Klein EA; Wood HM
Urology; 2014 Feb; 83(2):422-7. PubMed ID: 24315301
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of continence following 532 nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy.
No D; Osterberg EC; Otto B; Naftali I; Choi B
Lasers Surg Med; 2013 Aug; 45(6):358-61. PubMed ID: 23813669
[TBL] [Abstract][Full Text] [Related]
3. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
[TBL] [Abstract][Full Text] [Related]
4. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
5. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
Kollmeier MA; Stock RG; Cesaretti J; Stone NN
J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up.
Bouchier-Hayes DM; Van Appledorn S; Bugeja P; Crowe H; Challacombe B; Costello AJ
BJU Int; 2010 Apr; 105(7):964-9. PubMed ID: 19912196
[TBL] [Abstract][Full Text] [Related]
8. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
Sarosdy MF
Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
[TBL] [Abstract][Full Text] [Related]
9. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
Acher PL; Popert R; Morris SL; Potters L; Austin-Smith SL; Johnson UH; Nichol JE; Beaney RP
BJU Int; 2007 May; 99(5):1066-71. PubMed ID: 17233801
[TBL] [Abstract][Full Text] [Related]
10. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
[TBL] [Abstract][Full Text] [Related]
11. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the risk of postoperative infection between transurethral vaporesection and transurethral resection of the prostate.
May A; Broggi E; Lorphelin H; Tabchouri N; Giretti G; Pereira H; Bruyere F
Lasers Surg Med; 2014 Jul; 46(5):405-11. PubMed ID: 24665004
[TBL] [Abstract][Full Text] [Related]
13. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
[TBL] [Abstract][Full Text] [Related]
14. A comparison of 120 W laser photoselective vaporization versus transurethral resection of the prostate for bladder outlet obstruction by prostate cancer.
Altay B; Erkurt B; Kiremit MC; Horuz R; Guzelburc V; Albayrak S
Urol Int; 2015; 94(3):326-9. PubMed ID: 25721931
[TBL] [Abstract][Full Text] [Related]
15. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial.
Lukacs B; Loeffler J; Bruyère F; Blanchet P; Gelet A; Coloby P; De la Taille A; Lemaire P; Baron JC; Cornu JN; Aout M; Rousseau H; Vicaut E;
Eur Urol; 2012 Jun; 61(6):1165-73. PubMed ID: 22341632
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
[TBL] [Abstract][Full Text] [Related]
17. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia.
Nomura H; Seki N; Yamaguchi A; Naito S
Int J Urol; 2009 Aug; 16(8):657-62. PubMed ID: 19602003
[TBL] [Abstract][Full Text] [Related]
18. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
[TBL] [Abstract][Full Text] [Related]
19. Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate?
Luo HL; Fang FM; Kang CH; Chuang YC; Chiang PH
Int Urol Nephrol; 2013 Feb; 45(1):113-9. PubMed ID: 22972569
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
